Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Apr 2, 2018 · 10-K · 92 days after period end · 0001213900-18-003761
| Metric | Q4 2017 | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $32.19K | $58.20K | $23.15K | — |
| Net Income | -$86.41K | $135.28K | -$351.32K | -$235.27K |
| EPS Diluted | $0.00 | — |
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2017 · filed Apr 2, 2018 · 92 d after period end
